Alcon is a global medical company specializing in eye care products with headquarters in Geneva, Switzerland, and incorporated in Fribourg, Switzerland. Alcon’s American headquarters are located in Fort Worth, Texas. Alcon was a subsidiary of Novartis until April 9, 2019 when the company completed a shareholder approved 100% spinoff of Alcon eye care devices business from Novartis.
Index: NYSE; Sector: Technology; Industry: Scientific & Technical Instr.;
Marketcap: 27.70B; Volume: 907.01K; AvgVol 3m: 1.23M; Beta: –;
P/E: –; EPS: –; EPS growth quarter/prev quarter: ;
EPS growth this year: -54.00%; EPS growth past 5 years: ;
EPS ttm: -1.30;
P/S: 4.11; P/B: 1.49; P/Cashflow: ; P/FCF: ;
Sales: –; Sales growth quarter/prev quarter: -36.20%; Sales growth past 5 years: ;
Gross Margin: ; Profit Margin: ; Operating Margin: ;
ROA – return on assets: ; ROE – return on equity: ; LT Debt/Equity: ; Total Debt/Equity: ;
Dividend: –; Dividend Yield (%): –;
Insider Ownership: ; Insider Transactions:;
Institutional Ownership: 57.98%; Institutional Transactions: ;
Data update: 07.10.2020.